Regeneus Ltd

ASX:RGS ISIN:AU000000RGS6

Regeneus Ltd ASX:RGSRegeneus Ltd (ASX:RGS) is a Sydney-based clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies. The regenerative therapies seek to address unmet medical needs in human health markets, focusing on neuropathic pain, including osteoarthritis and various skin conditions, with its platform technologies Progenza(TM) and Sygenus. Visit www.regeneus.com.au for more information.

 
      
    

다른 언어로 보기

뉴스

###

216,622 회사 소개

  • 검색 횟수: (지난 7일간: 32) (지난 30일간: 150) (게재 이후: 26163) 

회사 데이터

    사령부
  • 2 Paddington Street
    Paddington NSW 2021
    Australia
  • 전화
  • +61-2-9499-8010 
  • 팩시밀리
  • +61-2-9499-8020 
  • 주요 분야
  • 제약 / 의료 
  • 주요 기업
  • Biotechnology 
  • 홈페이지
  • www.regeneus.com.au
  • E:
  • info@regeneus.com.au

더 많은 뉴스 보기

  • 2024/02/29: Half Yearly Report and Accounts*
  • 2024/02/23: Letter to Shareholders - GM*
  • 2024/02/23: Notice of General Meeting/Proxy Form*
*refer to company website

소셜 미디어